Thomas, McNerney & Partners
North America, Connecticut, United States, Stamford
Description
Thomas, McNerney & Partners is a health care venture capital firm with approximately $600 million under management focused on investing in
Investor Profile
Thomas, McNerney & Partners has backed more than 48 startups, with 0 new investments in the last 12 months alone. The firm has led 16 rounds, about 33% of its total and boasts 17 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series B, Series Unknown, Series C rounds (top funding stages).
- Majority of deals are located in United States, Israel.
- Strong thematic focus on Biotechnology, Health Care, Medical Device.
Stage Focus
- Series B (25%)
- Series Unknown (19%)
- Series C (15%)
- Series A (15%)
- Series D (13%)
- Series E (4%)
- Series F (4%)
- Post Ipo Equity (4%)
- Series G (2%)
Country Focus
- United States (98%)
- Israel (2%)
Industry Focus
- Biotechnology
- Health Care
- Medical Device
- Medical
- Therapeutics
- Pharmaceutical
- Biopharma
- Manufacturing
- Genetics
- Diabetes
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
